Research
We are translational researchers, working side by side with clinicians to get an even better understanding of the complex cardiovascular and pulmonary systems, gaining the insight needed to quickly turn discoveries into new therapies for people with or at risk for heart, lung or vascular disease. At the UC Heart, Lung & Vascular Institute, we drive toward these "Bench to Bedside" breakthroughs in treating cardiovascular and pulmonary disease.
Bench to Bedside three main methods of research:
- Basic science research
- Translational research
- Clinical research
The UC Heart, Lung & Vascular Institute strives to:
- Strengthen bridges between basic science and clinical research to accelerate discovery of safe, new treatments for heart, lung and vascular diseases and disorders.
- Support cutting-edge research that leads to novel technologies and therapeutics.
- Expand current research in promising new areas.
- Translate and commercialize new discoveries into products that can be used by clinicians to provide care to patients.
- Recruit prominent faculty to enhance research strengths.
Cutting edge of cardiovascular and pulmonary research
The UC Heart, Lung & Vascular Institute is a leader in the region, at the cutting-edge of cardiovascular and pulmonary research, and attracting large amounts of NIH funding. We were the first in the nation to show that: